https://doi.org/10.4081/aiua.2025.14073
P-wave dispersion in patients with premature ejaculation
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 6 August 2025
Background: Premature ejaculation (PE) is one of the common male sexual disorders and is associated with autonomic nervous system imbalance. P-wave dispersion (PWD), a marker of atrial electrical heterogeneity and a predictor of atrial arrhythmias, has not been previously investigated in the PE population. This study aimed to investigate PWD in patients with PE and to evaluate whether the subtypes of PE, namely acquired (APE) and lifelong (LLPE), differ in terms of atrial conduction parameters.
Methods: Seventy-eight male patients were included in the study. The distribution of patients was 40 healthy controls, 21 patients with APE, and 17 patients with LLPE. All patients underwent 12-lead electrocardiography to evaluate PWD. Echocardiographic, hormonal, and biochemical parameters were recorded to exclude confounding factors. PWD was defined as the difference between the maximum (Pmax) and minimum P-wave durations (Pmin).
Results: PWD was significantly increased in both PE groups compared to the control group (APE: 44.4 ± 4.1 ms; LLPE: 48.1 ± 2.1 ms; control: 38.2 ± 3.4 ms; p<0.001). Pmin was significantly lower in the PE groups, while Pmax remained comparable among all groups. There was no significant difference in PWD between the PE groups (p=0.38). All patients had normal echocardiographic and hormonal parameters, and there were no significant differences in age, body mass index, blood pressure, or heart rate between the groups.
Conclusions: PWD was significantly higher in patients with PE. This indicates that patients with PE are at a higher risk of developing cardiovascular diseases like atrial fibrillation.
Downloads
Martin C, Nolen H, Podolnick J, Wang R. Current and emerging therapies in premature ejaculation: where we are coming from, where we are going. Int J Urol. 2017; 24:40-50. DOI: https://doi.org/10.1111/iju.13202
Porst H, Montorsi F, Rosen RC, et al. The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol. 2007; 51:816-23. DOI: https://doi.org/10.1016/j.eururo.2006.07.004
Serefoglu EC, McMahon CG, Waldinger MD, et al. An evidencebased unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med. 2014; 2:41-59. DOI: https://doi.org/10.1002/sm2.27
Rowland D, Perelman M, Althof S, et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med. 2004; 1:225-32. DOI: https://doi.org/10.1111/j.1743-6109.2004.04033.x
Zorba OU, Cicek Y, Uzun H, et al. Autonomic nervous system dysfunction in lifelong premature ejaculation: analysis of heart rate variability. Urology. 2012; 80:1283-6. DOI: https://doi.org/10.1016/j.urology.2012.08.029
Erbay G, Ceyhun G. Is heart rate variability a risk factor for premature ejaculation? Int J Clin Pract. 2021; 75:e14699. DOI: https://doi.org/10.1111/ijcp.14699
Aytemir K, Ozer N, Atalar E, et al. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000; 23:1109-12. DOI: https://doi.org/10.1111/j.1540-8159.2000.tb00910.x
Sahin M, Bilgili SG, Simsek H, et al. Increased P-wave dispersion in patients with newly diagnosed lichen planus. Clinics (Sao Paulo). 2013; 68:846-50. DOI: https://doi.org/10.6061/clinics/2013(06)20
Yasar E, Yilmaz B, Yasar AS, et al. Effect of autonomic dysfunction on P-wave dispersion in patients with chronic spinal cord injury. Am J Phys Med Rehabil. 2010; 89:824-30. DOI: https://doi.org/10.1097/PHM.0b013e3181f1ba2c
Dilaveris PE, Gialafos EJ, Sideris SK, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J. 1998; 135:733-8. DOI: https://doi.org/10.1016/S0002-8703(98)70030-4
Aditi R, Sathasivasubramanian S, Bhaskar ME. Association of oral lichen planus and electrocardiographic P-wave dispersion - An original research. Braz Dent J. 2017; 28:699-703. DOI: https://doi.org/10.1590/0103-6440201701570
Büyükkuscu A, Zeynelova G, Oflaz U, et al. P-wave dispersion in acute pancreatitis. Arch Basic Clin Res. 2024; 6:96-100. DOI: https://doi.org/10.5152/ABCR.2024.24253
Kumar U, Agrawal M, Varma K, et al. Study of P-wave dispersion in patients of psoriasis: An observational study. Indian J Clin Exp Dermatol. 2023; 9:66-71. DOI: https://doi.org/10.18231/j.ijced.2023.012
Baykara S, Yılmaz M, Baykara M. QT dispersion and P wave dispersion in schizophrenia. Psychiatry Clin Psychopharmacol 2019;29:538-43. DOI: https://doi.org/10.1080/24750573.2018.1472906
Amirghofran S, Aslani A, Zakerinia M. Investigation of P-wave dispersion in adult patients with beta-thalassemia major. J Cardiovasc Disease Res. 2016; 7:116-9. DOI: https://doi.org/10.5530/jcdr.2016.3.4
Bayır PT, Güray Ü, Duyuler S, et al. Assessment of atrial electromechanical interval and P wave dispersion in patients with polycystic ovary syndrome. Anatol J Cardiol. 2016; 16:100-5.
Öncel CR, Akkoç A. P wave dispersion in patients with erectile dysfunction. Interv Med Appl Sci. 2019; 11:101-5. DOI: https://doi.org/10.1556/1646.11.2019.10
Inci S, Nar G, Aksan G, et al. P-wave dispersion and atrial electromechanical delay in patients with preeclampsia. Med Princ Pract. 2015; 24:515-21. DOI: https://doi.org/10.1159/000435857
Yolbas S, Yıldırım A, Düzenci D, et al. QT dispersion and P wave dispersion in patients with fibromyalgia. Eur J Rheumatol. 2016;3:165-8. DOI: https://doi.org/10.5152/eurjrheum.2016.042
Kutsal C, Albayrak AT, Abdullayev E, et al. Retrospective evaluation of P-wave dispersion on ECG in terms of atrial fibrillation dispersion in patients using alpha-blockers for lower urinary tract symptoms. Med J Bakirkoy. 2023; 19:31-4. DOI: https://doi.org/10.4274/BMJ.galenos.2023.2023.1-3
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.